Brief: Suven Pharmaceuticals Says Shareholders Of Cohance Will Be Issued Shares Of Co At Ratio Of 11 Shares Of Co For Every 295 Shares Of Cohance
Feb 29 (Reuters) - Suven Pharmaceuticals Ltd SUVH.NS :
* SUVEN PHARMACEUTICALS - SHAREHOLDERS OF COHANCE WILL BE
ISSUED
SHARES OF CO AT RATIO OF 11 SHARES OF CO FOR EVERY 295 SHARES OF
COHANCE
* SUVEN PHARMACEUTICALS - NEW SHARES OF SUVEN ISSUED WILL BE
TRADED ON NSE AND BSE
* SUVEN PHARMACEUTICALS - ADVENT ENTITIES SHALL OWN ABOUT
66.7%
AND PUBLIC SHAREHOLDERS WILL HOLD ABOUT 33.3% OF COMBINED ENTITY
* SUVEN PHARMACEUTICALS - TRANSACTION EXPECTED TO CONCLUDE
OVER
NEXT 12-15 MONTHS
Source text for Eikon: ID:nBSE76tfM9
Further company coverage: SUVH.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss